Skip to main content
Clinical Trials/NL-OMON54610
NL-OMON54610
Recruiting
Not Applicable

Treating PTSD in patients with co-occurring substance use disorders: a randomized controlled trial to compare the efficacy of different types and timing of treatment. - Treatment Of PTSD and Addiction (TOP-A)

Arkin (Amsterdam)0 sites205 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Arkin (Amsterdam)
Enrollment
205
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Arkin (Amsterdam)

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • \- age 18 years or older;
  • \- substance use disorder(s) according to the Diagnostic and Statistical Manual
  • of Mental Disorders 5 criteria (DSM\-5; American Psychiatric Association, 2013\)
  • with a primary diagnosis involving one of the following substances: alcohol,
  • cannabis, cocaine (snorting) amphetamine, benzodiazepine, opioid.
  • \- posttraumatic stress disorder according to the DSM\-5 criteria;
  • \- sufficient understanding of the Dutch language.

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study: \- acute psychotic disorder; \- mental
  • retardation or cognitive impairment (estimated IQ\<70\); \- current physical or
  • sexual abuse or death threats; \- suicidal behavior; (A suicide attempt during
  • the past 3 month or acute suicidal ideations according to the MINI) \- life
  • threatening self\-mutilation; \- homelessness. \- involvement in a compensation
  • case or legal procedures concerning admission or stay in the Netherlands \-
  • involvement in legal procedures regarding the index trauma \- engagement in any
  • other current PTSD treatment Current amendement: \- Explicit indication at the
  • baseline IC that they do not wish to be approached for future research

Outcomes

Primary Outcomes

Not specified

Similar Trials